Tag: our research

In 2022, Professor Petra Hamerlik was appointed as The Brain Tumour Charity’s Chair of Translational Neuro-oncology, at the University of Manchester’s Cancer Research Centre.

Research we’re funding in partnership with The Oli Hilsdon Foundation at University College London is using advanced brain mapping to reveal how glioblastoma spreads and resists treatment, providing insight for potential new treatments.

This year has been an exciting year for our research. Read more as we share some of 2024’s best bits.

Involvement volunteer Baljit Ahluwalia lost her mother, Harbans Kaur Walia, to glioblastoma in 2020.

Bryony Powell knew very little about brain tumours before her fiancé, Catherine Roberts, was diagnosed with a glioblastoma in April 2018.

We are pleased to announce the two researchers who have been awarded our latest Expanding Theories grant!

The biennial CRUK Brain Tumour Conference returned to London for 2024.

Researchers in Newcastle have found a key genetic variation in medulloblastomas that may pave the way for more effective targeted treatments.

We’re proud to announce the latest recipients of our Future Leaders grants that’ve been awarded for their innovative new research projects.

Our Junior Fellow Dr Spencer Watson and his team at The Ludwig Institute for Cancer Research at the University of Lausanne in Switzerland are researching new ways to treat glioblastoma.

This month we sponsored an event in Manchester which brought together brain tumour experts to talk about new technologies that could improve brain tumour care.

With our funding, researchers in Canada have found key features in different meningiomas that can help predict tumour response to the most common treatments.

Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma.

One of our first Junior Fellowship grant holders, Dr Tyler Miller, has opened his own research lab focused on developing immunotherapies to treat brain tumours.

The Ways Ahead project aims to find ways to support, and improve quality of life for those diagnosed with a lower-grade brain tumour. It also explores ways to help friends and family who are supporting those diagnosed.

We are pleased to announce the two researchers who have been awarded our latest Expanding Theories grant!

Research that we funded nearly 20 years ago laid the foundations for last week’s approval of dabrafenib and trametinib to treat childhood gliomas.

CAR-T cell therapy is a type of immunotherapy that may be promising for treating brain tumours. There is lots of research in this field across the globe and it may one day be used more widely to treat this devastating disease.

Peter Buckle is a patient advocate and has worked with several teams, including the ARISTOCRAT team to champion research and clinical trials.

Dr Veronica Rendo, a researcher funded by The Brain Tumour Charity, shared the findings of her work at the annual meeting of the Society for Neuro-Oncology.

We are pleased to announce that The Brain Tumour Charity has joined the Cancer Tech Accelerator 3.0 as a new funding partner!

Two of our funded researchers have won awards at the Society for Immunotherapy of Cancer (SITC) annual conference!

We are pleased to announce the two researchers who have been awarded the Junior Fellowship grant – the second award in our Future Leaders programme!

We are pleased to announce that we have awarded £4.5 million to three new, exciting research initiatives.